Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析

◆英語タイトル:Interpace Biosciences Inc (IDXG) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME63409PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform. It also provides ThyGenX and ThyraMIR that collectively assess the risk of benign or malignant thyroid nodules, and minimizes unnecessary surgeries. Interpace Biosciences offers diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers. The company operates through its labs located in Pennsylvania, Pittsburgh, and New Haven, the US. Interpace Biosciences is headquartered in Parsippany, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Interpace Biosciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Interpace Biosciences Inc Company Overview
Interpace Biosciences Inc Company Snapshot
Interpace Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
Interpace Biosciences Inc – Pipeline Analysis Overview
Interpace Biosciences Inc – Key Facts
Interpace Biosciences Inc – Major Products and Services
Interpace Biosciences Inc Pipeline Products by Development Stage
Interpace Biosciences Inc Ongoing Clinical Trials by Trial Status
Interpace Biosciences Inc Pipeline Products Overview
BarreGen
BarreGen Product Overview
BarreGen Clinical Trial
Diagnostic Assay – Biliary Cancer
Diagnostic Assay – Biliary Cancer Product Overview
Diagnostic Test – Pancreatobiliary Cancer
Diagnostic Test – Pancreatobiliary Cancer Product Overview
Dyslexia Predisposition Test
Dyslexia Predisposition Test Product Overview
PancraMir
PancraMir Product Overview
PathFinderTG – Colon (Supernatant)
PathFinderTG – Colon (Supernatant) Product Overview
PathFinderTG – IBD
PathFinderTG – IBD Product Overview
PathFinderTG – Pancreas (Supernatant)
PathFinderTG – Pancreas (Supernatant) Product Overview
PathFinderTG – Ulcerative Colitis Supernatant
PathFinderTG – Ulcerative Colitis Supernatant Product Overview
PathFinderTG MvP Dx
PathFinderTG MvP Dx Product Overview
Serology Test – COVID-19
Serology Test – COVID-19 Product Overview
ThyGeNEXT
ThyGeNEXT Product Overview
ThyGeNEXT Clinical Trial
ThyraMIR
ThyraMIR Product Overview
ThyraMIR Clinical Trial
Interpace Biosciences Inc – Key Competitors
Interpace Biosciences Inc – Key Employees
Interpace Biosciences Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Interpace Biosciences Inc, Recent Developments
Mar 10, 2020: Interpace Diagnostics announces contract with BCBS of Massachusetts
Mar 02, 2020: Interpace Biosciences announces acceptance of first paper demonstrating clinical performance of ThyGeNEXT with ThyraMIR
Feb 24, 2020: Interpace announces extension of LabCorp agreement
Feb 11, 2020: Interpace Biosciences announces another pricing improvement for its Thyroid Assay
Jan 06, 2020: Interpace Biosciences announces collaborative study with University of North Carolina to assess the use BarreGEN after Ablation of dysplastic barrett’s esophagus
Dec 17, 2019: Interpace Biosciences announces new draft LCD and reimbursement for its proprietary thyroid assay, ThyGeNEXT
Oct 29, 2019: Interpace to present data at the ATA Annual Meeting
Oct 24, 2019: Interpace to present at the American College of Gastroenterology Conference
Sep 30, 2019: Interpace announces new contracts with Multiple Blue Cross Blue Shield Plans
Sep 16, 2019: Interpace enters strategic partnership agreement with Genecast Biotechnology to partner with Biopharma Solutions in China
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Interpace Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
Interpace Biosciences Inc Pipeline Products by Equipment Type
Interpace Biosciences Inc Pipeline Products by Indication
Interpace Biosciences Inc Ongoing Clinical Trials by Trial Status
Interpace Biosciences Inc, Key Facts
Interpace Biosciences Inc, Major Products and Services
Interpace Biosciences Inc Number of Pipeline Products by Development Stage
Interpace Biosciences Inc Pipeline Products Summary by Development Stage
Interpace Biosciences Inc Ongoing Clinical Trials by Trial Status
Interpace Biosciences Inc Ongoing Clinical Trials Summary
BarreGen - Product Status
BarreGen - Product Description
BarreGen - A Collaborative Study to Evaluate the Use of BarreGen after Ablation of Dysplastic Barrett’s Esophagus
Diagnostic Assay - Biliary Cancer - Product Status
Diagnostic Assay - Biliary Cancer - Product Description
Diagnostic Test - Pancreatobiliary Cancer - Product Status
Diagnostic Test - Pancreatobiliary Cancer - Product Description
Dyslexia Predisposition Test - Product Status
Dyslexia Predisposition Test - Product Description
PancraMir - Product Status
PancraMir - Product Description
PathFinderTG - Colon (Supernatant) - Product Status
PathFinderTG - Colon (Supernatant) - Product Description
PathFinderTG - IBD - Product Status
PathFinderTG - IBD - Product Description
PathFinderTG - Pancreas (Supernatant) - Product Status
PathFinderTG - Pancreas (Supernatant) - Product Description
PathFinderTG - Ulcerative Colitis Supernatant - Product Status
PathFinderTG - Ulcerative Colitis Supernatant - Product Description
PathFinderTG MvP Dx - Product Status
PathFinderTG MvP Dx - Product Description
Serology Test - COVID-19 - Product Status
Serology Test - COVID-19 - Product Description
ThyGeNEXT - Product Status
ThyGeNEXT - Product Description
ThyGeNEXT - Clinical Utility Combination Thyroid Test
ThyraMIR - Product Status
ThyraMIR - Product Description
ThyraMIR - Clinical Utility Combination Thyroid Test
Interpace Biosciences Inc, Key Employees
Interpace Biosciences Inc, Subsidiaries
Glossary

★海外企業調査レポート[Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exelixis Inc (EXEL):企業の財務・戦略的SWOT分析
    Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • SilverSun Technologies Inc (SSNT):企業の財務・戦略的SWOT分析
    Summary SilverSun Technologies Inc (SilverSun) is a technology company that offers transformational business technology solutions and services for manufacturers and distributors. The company’s ERP software products comprise ERP X3, MAS90 and MAS200. It offers network services such as 24/7 remote net …
  • Central Petroleum Ltd (CTP):企業の財務・戦略的SWOT分析
    Summary Central Petroleum Ltd (CPL) operates as an oil and gas company that offers exploration and development services. The company develops, produces, processes and markets hydrocarbons. It operates its oil and gas assets in Amadeus basin, Pedirka basin, Georgina basin, and Wiso basin. CPL’s Amade …
  • Senseonics Inc:企業の戦略的SWOT分析
    Senseonics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Cardinal Ethanol LLC:企業の戦略的SWOT分析
    Cardinal Ethanol LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Murree Brewery Co. Ltd.
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BP Plc (BP.)-石油・ガス分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • QuadGraphics, Inc. (QUAD):企業の財務・戦略的SWOT分析
    QuadGraphics, Inc. (QUAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Avadel Pharmaceuticals Plc (AVDL):製薬・医療:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • Torque Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic and solid tumors; Deep IL-12 targeting solid tumors; and small-molecule Deep T …
  • Glenmark Pharmaceuticals Ltd (GLENMARK):企業の財務・戦略的SWOT分析
    Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • PT ANTAM (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nordex SE (NDX1)-エネルギー分野:企業M&A・提携分析
    Summary Nordex SE (Nordex) is a manufacturer of wind turbines. Along with its subsidiaries, the company conducts the development, production, servicing and marketing of wind power systems. The service portfolio related to technical planning of wind farm systems ranges from the identification of suit …
  • Entergy Corporation (ETR):電力:M&Aディール及び事業提携情報
    Summary Entergy Corporation (Entergy) is an integrated energy company that generates, transmits, distributes and sells electricity. The company generates electricity from various sources including natural gas, nuclear, coal, hydroelectric, solar and oil based power plants. Entergy also operates natu …
  • Country Club Hospitality & Holidays Ltd.:企業の戦略・SWOT・財務分析
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • DowDuPont Inc (DWDP):企業の財務・戦略的SWOT分析
    DowDuPont Inc (DWDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Boule Diagnostics AB (BOUL):企業の財務・戦略的SWOT分析
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • AUDI AG:企業の戦略・SWOT・財務情報
    AUDI AG - Strategy, SWOT and Corporate Finance Report Summary AUDI AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務情報
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆